U.S. markets open in 13 minutes

Welltower Inc. (WELL)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
69.02+0.40 (+0.58%)
At close: 4:04PM EST

69.13 +0.11 (0.16%)
Pre-Market: 9:13AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close68.62
Bid67.51 x 1100
Ask69.59 x 900
Day's Range67.95 - 69.60
52 Week Range24.27 - 78.82
Avg. Volume2,532,568
Market Cap28.808B
Beta (5Y Monthly)1.04
PE Ratio (TTM)29.62
EPS (TTM)2.33
Earnings DateMay 04, 2021 - May 10, 2021
Forward Dividend & Yield2.44 (3.54%)
Ex-Dividend DateFeb 19, 2021
1y Target Est66.36
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-15% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Genesis HealthCare Shares Are Trading Lower After Debt Restructuring Deal, Voluntary Delisting From NYSE

    Welltower Inc (NYSE: WELL) is cutting most ties with beleaguered Genesis HealthCare Inc (NYSE: GEN) and plans to terminate leases with Genesis for 51 of its properties and provide an $86 million lease termination fee upon their successful transition. Additionally, Genesis will conditionally receive approximately $170 million in additional debt reductions from Welltower. Hence, Genesis expects to reduce its debt outstanding to Welltower by approximately $256 million and extend the maturity to January 1, 2024. Welltower will also receive equity in Genesis, increasing its stake in Genesis from approximately 6% to about 15%. It has also secured a $50 million debt investment from ReGen Healthcare that would convert into equity representing a 25% stake in the company. ReGen Healthcare also has the option to make an additional debt investment of $25 million exercisable no later than March 31 and to be funded by April 15. As part of the agreement, two Genesis Board Members, John F. DePodesta and Terry Rappuhn have relinquished their current positions. ReGen Healthcare has appointed David Harrington and John Randazzo, effective immediately. Also, Mr. Harrington has been appointed Chairman of the Board. Concurrently, Genesis intends to voluntarily delist from the New York Stock Exchange by March 25. Following the deregistration, the company anticipates that its Common Stock will be quoted on the OTC Pink Open Market. The company expects to file its 2020 Form 10-K by March 16, but it will not distribute a Q4 2020 earnings release or host a conference call. Price Action: GEN shares dropped 35.9% at $0.52, and WELL stock is up 0.48% at $68.95 in market trading hours on the last check Wednesday. See more from BenzingaClick here for options trades from BenzingaNovavax Partners With Poland's Mabion For COVID-19 Vaccine Production: BloombergVir Biotechnology Shares Are Trading Lower As COVID-19 Study VIR-7831 Arm To Stop Enrollment© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Welltower (WELL) Limits Genesis Ties, Enhances ProMedica JV

    Welltower (WELL) Limits Genesis Ties, Enhances ProMedica JV

    While the future deployment of $745 million of Genesis transaction proceeds offers significant value accretion scope for Welltower (WELL), the sale of properties will result in earnings dilution.

  • Welltower's (WELL) Seniors Housing Occupancy Slips in February

    Welltower's (WELL) Seniors Housing Occupancy Slips in February

    The resurgence of COVID-19 cases in December and January is likely to have resulted in a 220-basis-point occupancy loss for Welltower's (WELL) seniors housing portfolio in February.